Online Exclusives
-
Dietary Supplements | Herbs & Botanicals | Regulations
CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
Stakeholders disappointed by agency inaction but welcome chance to influence legislation.By Sean Moloughney, Editor 01.31.23
-
Dietary Supplements | Herbs & Botanicals | Regulations
Natural Products Association Blasts FDA for Punting CBD Issues to Congress
FDA rejected NPA’s petition that asked the agency to clear a regulatory pathway for CBD and to review safety data from cbdMD.By Sean Moloughney, Editor 01.27.23
-
Dietary Supplements | Herbs & Botanicals | Regulations
FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
In response letters, agency says NDI process not robust enough to ensure applicable safety standards are met.By Sean Moloughney, Editor 01.26.23
-
Dietary Supplements | Regulations | Weight Management/Weight Loss
Bill to Restrict Access to Supplements Vetoed in New York
Gov. Kathy Hochul claimed the bill was too burdensome on the Department of Health.By Mike Montemarano, Associate Editor 01.03.23
-
Dietary Supplements
The Top 10 Articles of 2022 on NutraceuticalsWorld.com
These stories were read the most throughout the year.12.23.22
-
Digestive Health | Healthcare Trends | Inflammation | Mood Health & Sleep
The Gut Doctor: Functional Medicine Practitioner Dr. Sonza Curtis Gets Into The Belly of Good Health
A functional medicine consultant based in Atlanta, GA, Curtis specializes in holistic gut health and autoimmune issues.By Lianna Albrizio, Assistant Editor 12.22.22
-
Dietary Supplements | Regulations
Regulatory Challenges Persist for Dietary Supplement Stakeholders
Experts discussed structure-function claims, drug preclusion issues, and more at AHPA’s Regulatory Congress.By Mike Montemarano, Associate Editor 12.20.22
-
Dietary Supplements
What People Were Reading in November 2022 on NutraceuticalsWorld.com
Our most-viewed stories in November included functional food trends as well as FDA action on NMN and heart disease claims.12.20.22
-
Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Mergers & Acquisitions | Regulations
Top Trends in CBD: 2022 Market Year in Review
Regulatory uncertainty has held innovation back, but companies are moving forward with science and on-trend formulations.By Sheldon Baker, Baker Dillon Group 12.19.22
-
Dietary Supplements | Healthcare Trends | Healthy Aging
Personalized Nutrition: A Steep Learning Curve for the Dietary Supplement Market
With science still emerging, companies face sizable challenges when it comes to delivering precision nutrition products.By Mike Montemarano, Associate Editor 12.16.22
-
Consumer Trends | Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements
Manufacturing Gummies: Opportunities for Nutraceuticals and Pharmaceuticals
Fueled by consumer preference, process innovations are opening up new possibilities in dose delivery.By Michael Stott, Partner, Mathys & Squire LLP 12.12.22
-
Enzymes | Mergers & Acquisitions | Mood Health & Sleep | Probiotics & Prebiotics | Vitamins
Novozymes OneHealth Debuts in U.S. to Target ‘Profound’ Consumer Health Challenges
Company aims to ‘rethink tomorrow’ with diverse, clinically substantiated product portfolio.By Sean Moloughney, Editor 12.09.22
-
Dietary Supplements | Herbs & Botanicals | Regulations
FDA Warning Letters Take Aim at Foods and Beverages Containing CBD
Recent batches of warning letters signal the agency’s focused on more than disease claims.By Mike Montemarano, Associate Editor 11.28.22
-
Dietary Supplements | Regulations | Weight Management/Weight Loss
Weight Loss, Muscle Building In the Crosshairs
Experts discussed legislative efforts to restrict access to certain dietary supplement categories.By Mike Montemarano, Associate Editor 11.28.22
-
Dietary Supplements | Herbs & Botanicals | Quality & Safety | Testing
‘Burn It, Don’t Return It’: The Duty to Destroy Adulterated Material
Experts discuss how companies can guard against adulteration and build in procedures for when issues arise.By Mike Montemarano, Associate Editor 11.18.22
-
Dietary Supplements | Regulations
NDI Déjà vu: Another Ingredient Falls Victim to FDA’s Interpretation of Drug Preclusion Clause
Agency rejected an NDI notification from Kingdomway saying beta nicotinamide-mononucleotide was first investigated as a new drug.By Mike Montemarano, Associate Editor 11.15.22
-
Cancer Risk | Fiber & Carbohydrates | Probiotics & Prebiotics | Research
Resistant Starch Associated with 60% Reduction in Upper GI Cancer Among Lynch Syndrome Patients
Individuals with Lynch Syndrome have significantly increased risk of developing many types of cancer.11.14.22
-
Dietary Supplements
What People Were Reading in October 2022 on NutraceuticalsWorld.com
Our most-viewed stories in October covered regenerative agriculture, new supplement usage data, and more.11.14.22
-
Herbs & Botanicals | Regulations
AHPA Regulatory Congress to Cover Range of Priorities for Natural Products Market
Nov. 15 virtual sessions will discuss FDA activity, sports nutrition product access, hemp, midterm election outcomes, and more.By Sean Moloughney, Editor 11.14.22
-
Dietary Supplements | Functional Foods & Beverages
Participate in Our Fifth Annual State of the Nutraceuticals Industry Survey
Take just a few minutes for a chance to win a $100 American Express gift card.10.31.22
